Viewing Study NCT05917561


Ignite Creation Date: 2025-12-24 @ 12:54 PM
Ignite Modification Date: 2025-12-28 @ 11:16 AM
Study NCT ID: NCT05917561
Status: RECRUITING
Last Update Posted: 2023-12-22
First Post: 2023-05-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
Sponsor: University Hospital, Bordeaux
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module